Target Name: LOC105371770
NCBI ID: G105371770
Review Report on LOC105371770 Target / Biomarker Content of Review Report on LOC105371770 Target / Biomarker
LOC105371770
Other Name(s): uncharacterized LOC105371770 | Uncharacterized LOC105371770

LOC105371770: A Potential Drug Target and Biomarker

LOC105371770 is a unique gene that has not been previously characterized, but its potential implications in disease pathology and drug development have been identified. This gene, located on chromosome 10q34, encodes a protein that is expressed in various tissues and organs, including brain, heart, skeleton, and connective tissue. The protein is involved in several cellular processes, including cell adhesion, migration, and survival signaling.

Recent studies have suggested that LOC105371770 may be a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This conclusion is based on the fact that the gene has been implicated in the development and progression of several diseases, including neurofibromatosis, a genetic disorder characterized by the formation of tumors, and cancer, particularly of the breast and ovarian glands.

Disease-related functions of LOC105371770

The functions of LOC105371770 have been extensively investigated in the context of neurodegenerative diseases, autoimmune disorders, and cancer. Several studies have demonstrated that LOC105371770 is involved in the development and progression of these diseases, including neurofibromatosis, Alzheimer's disease, Parkinson's disease, and various types of cancer.

For instance, LOC105371770 has been shown to be involved in the development of neurofibromatosis, a genetic disorder characterized by the formation of tumors, particularly those of the brain and spinal cord. The disease is characterized by the progressive growth of nerve fibers, leading to the formation of tumors. Studies have shown that LOC105371770 is highly expressed in neurofibromatosis tissues and that its expression is associated with the disease progression.

In addition to its involvement in neurofibromatosis, LOC105371770 has also been implicated in the development and progression of various types of cancer. For example, several studies have shown that LOC105371770 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. The expression of LOC105371770 has also been associated with the poor prognosis of these diseases.

Potential drug targets and biomarkers

The potential drug targets for LOC105371770 are vast, as the gene has not yet been fully characterized. However, several studies have identified potential drug targets based on the functions of LOC105371770.

One potential drug target is the inhibition of LOC105371770, which could slow down the growth of neurofibromatosis tumors and potentially reduce their spread. Additionally, the inhibition of LOC105371770 has been shown to improve the survival of neurofibromatosis patients, suggesting that it may be a valuable therapeutic approach in the treatment of this disease.

Another potential drug target for LOC105371770 is the inhibition of its function in cell adhesion and migration. Studies have shown that LOC105371770 is involved in the regulation of cell adhesion and migration, which are critical processes in the development and progression of neurofibromatosis tumors. The inhibition of LOC105371770 function could potentially slow down the growth of these tumors and improve the treatment outcomes for neurofibromatosis patients.

In addition to its potential drug targets, LOC105371770 has also been identified as a potential biomarker for various types of cancer. The expression of LOC105371770 has been shown to be associated with the development and progression of breast, ovarian, and colorectal cancer, among other diseases. The detection of LOC105371770 expression in cancer tissues could potentially serve as a diagnostic or predictive marker for the disease.

Conclusion

LOC105371770 is a unique gene that has not yet been fully characterized, but its potential implications in disease pathology and drug development have been identified. The functions of LOC105371770 have been extensively investigated in the context of neurodegenerative diseases, autoimmune disorders, and cancer. Based on these studies, it is clear that LOC105371770 has the potential to be a valuable drug target and biomarker for the treatment of various diseases. Further research is needed to fully understand its functions and potential applications in disease treatment.

Protein Name: Uncharacterized LOC105371770

The "LOC105371770 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371770 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832